Akers Biosciences Jumps On COVID-19 Vaccine Progress, Will Remain Volatile [Seeking Alpha]
AKERS BIOSCIENCES INC COMMON S (AKER)
US:NASDAQ Investor Relations:
akersbio.com/investor-center
Company Research
Source: Seeking Alpha
SummaryThe licensing deal between Akers Biosciences and Premas Biotech is already starting to show promise.Together, the companies are working to find a vaccine to treat COVID-19, as well as use Akers' expertise in navigating the regulatory hurdles in order to expedite the process.In early April, the companies announced they had successfully acquired clones of the three coronavirus antigens they're using to develop the vaccine.We'll also look at some the numbers for full-year 2019, which, while falling short on revenue, improved significantly with gross margins and lower costs.Source:marketbeatIn March, the obscure biotech company Akers Biosciences (NASDAQ:AKERentered into a licensing dealAt the time, the share price of the company predictably jumped on the news, as traders quickly entered and exited positions in the company. The firm recently soared much more on news of its advancement in the next stage of the development process.In this article, we'll look closer at the vaccine bein
Show less
Read more
Impact Snapshot
Event Time:
AKER
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
AKER alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
AKER alerts
High impacting AKERS BIOSCIENCES INC COMMON S news events
Weekly update
A roundup of the hottest topics